在发展中国家的结核病和人类免疫缺陷病毒感染.

Methodology and scope of peer-reviewed evaluations of TB programmes in high-incidence settings: a scoping review.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026

Early interventions reduce multimorbidity and TB disability in Kenya, Uganda, Zambia, and Zimbabwe.

IJTLD open·2026

Operational research to End TB: 2<sup>nd</sup> edition of the Union's Guide to operational research.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025

Kartagener Syndrome: A First Report of Two Cases from Benin, West Africa.

West African journal of medicine·2025

Evaluating disability, comorbidities and risk factors after TB treatment: an 18-24 month follow-up.

IJTLD open·2025

TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe.

IJTLD open·2025

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

The Correlation between Erythrocyte Sedimentation Rate and C-reactive Protein Ratio, and Lipid Profile in Dyslipidemia Patients with Dry Eye Disease.

Recent advances in inflammation & allergy drug discovery·2026

Interplay of physical activity and sleep in modulating heart rate variability: insights from adults with major depressive disorder.

Frontiers in physiology·2026

Management of Tuberculosis at El-Obeid Teaching Hospital During the Sudanese Armed Conflict: A Single-Center Descriptive Study.

Cureus·2026

Clinical Series of Endogenous Klebsiella Endophthalmitis: Understanding an Aggressive Invasive Pathogen.

Cureus·2026

Post-Thrombotic Syndrome of Lower Extremity.

Clinical case reports·2026

Hypoglycemia aggravates cognitive degeneration by activating endothelial ZBP1-mediated PANoptosis in type 2 diabetic mice.

Frontiers in pharmacology·2026

相关实验视频

在发展中国家的结核病和人类免疫缺陷病毒感染.

相关概念视频

Methodology and scope of peer-reviewed evaluations of TB programmes in high-incidence settings: a scoping review.

Early interventions reduce multimorbidity and TB disability in Kenya, Uganda, Zambia, and Zimbabwe.

Operational research to End TB: 2<sup>nd</sup> edition of the Union's Guide to operational research.

Kartagener Syndrome: A First Report of Two Cases from Benin, West Africa.

Evaluating disability, comorbidities and risk factors after TB treatment: an 18-24 month follow-up.

TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

The Correlation between Erythrocyte Sedimentation Rate and C-reactive Protein Ratio, and Lipid Profile in Dyslipidemia Patients with Dry Eye Disease.

Interplay of physical activity and sleep in modulating heart rate variability: insights from adults with major depressive disorder.

Management of Tuberculosis at El-Obeid Teaching Hospital During the Sudanese Armed Conflict: A Single-Center Descriptive Study.

Clinical Series of Endogenous Klebsiella Endophthalmitis: Understanding an Aggressive Invasive Pathogen.

Post-Thrombotic Syndrome of Lower Extremity.

Hypoglycemia aggravates cognitive degeneration by activating endothelial ZBP1-mediated PANoptosis in type 2 diabetic mice.

相关实验视频

在发展中国家的结核病和人类免疫缺陷病毒感染.

相关概念视频

相关文章